Currás-Collazo M C, Chin C, Díaz G, Stivers C, Bozzetti L, Tran L Y
Department of Neuroscience, University of California at Riverside, Riverside, California 92521, USA.
J Comp Neurol. 2000 Nov 6;427(1):93-108. doi: 10.1002/1096-9861(20001106)427:1<93::aid-cne6>3.0.co;2-8.
Previous studies suggest that activation of N-methyl-D-aspartate (NMDA) receptors facilitates phasic firing and spike clustering displayed by magnocellular neuroendocrine cells (MNCs) of the supraoptic (SON) and paraventricular nucleus of the hypothalamus (PVN). Osmotic stimulation produces similar activity patterns which, in turn, can lead to enhanced release of vasopressin and oxytocin from MNCs. Our laboratory has shown that dehydration regulates the expression of the NMDA receptor subunits, NR1 and NR2B, in the SON and PVN, suggesting their involvement in osmoregulation. In the present study, we examined the cellular localization of NR2B, one of the glutamate-binding subunits of the NMDA receptor, with an NR2B-specific antibody. Using double-label immunohistochemistry and three different detection methods with metallic, peroxidase, and fluorescence markers, it was found that both vasopressin and oxytocin-producing MNC populations synthesize NR2B. The incidence of NR2B colocalization with vasopressin-neurophysin in the SON and lateral magnocellular PVN (PVL) was 0.95 and 0.91, respectively. For oxytocin-neurophysin, the corresponding values were 0.97 and 0.95, respectively. Furthermore, the extent of colocalization in MNCs of the SON, PVL, retrochiasmatic SON, and accessory neurosecretory nuclei was similar. Astrocytes associated with the SON, and identified with antibodies targeting glial fibrillary acidic protein (GFAP) or vimentin, were not colabeled with NR2B. Our results demonstrate that NR2B protein is expressed by almost all MNCs and that it is equally prevalent in vasopressinergic and oxytocinergic populations of various magnocellular neuroendocrine nuclei supporting a role of NMDA receptors in MNC-mediated neurosecretory processes. Although NR2B may form part of functional NMDA receptors on MNCs, it is probably not present on astrocytes associated with nearby MNCs.
先前的研究表明,N-甲基-D-天冬氨酸(NMDA)受体的激活促进了下丘脑视上核(SON)和室旁核(PVN)的大细胞神经内分泌细胞(MNCs)所表现出的相位性放电和峰电位簇集。渗透压刺激会产生类似的活动模式,进而导致MNCs中血管加压素和催产素的释放增加。我们实验室已经表明,脱水调节SON和PVN中NMDA受体亚基NR1和NR2B的表达,表明它们参与渗透压调节。在本研究中,我们使用NR2B特异性抗体检查了NMDA受体的谷氨酸结合亚基之一NR2B的细胞定位。使用双标记免疫组织化学以及金属、过氧化物酶和荧光标记物三种不同的检测方法,发现产生血管加压素和催产素的MNC群体均合成NR2B。在SON和外侧大细胞PVN(PVL)中,NR2B与血管加压素-神经垂体素共定位的发生率分别为0.95和0.91。对于催产素-神经垂体素,相应的值分别为0.97和0.95。此外,SON、PVL、视交叉后SON和副神经分泌核的MNC中共定位的程度相似。与SON相关并通过靶向胶质纤维酸性蛋白(GFAP)或波形蛋白的抗体鉴定的星形胶质细胞未与NR2B共标记。我们的结果表明,NR2B蛋白几乎在所有MNCs中表达,并且在各种大细胞神经内分泌核的血管加压素能和催产素能群体中同样普遍,支持NMDA受体在MNC介导的神经分泌过程中的作用。尽管NR2B可能是MNCs上功能性NMDA受体的一部分,但它可能不存在于与附近MNCs相关的星形胶质细胞上。